Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, phase II trials

Dengue is prevalent in the Asia-Pacific region. Participants of two immunogenicity and safety phase II studies conducted in Singapore and Vietnam (NCT0088089 and NCT00875524, respectively) were followed for up to four years after third vaccine dose of a recombinant, live, attenuated, tetravalent den...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hum Vaccin Immunother
Main Authors: Tran, Ngoc Huu, Chansinghakul, Danaya, Chong, Chia Yin, Low, Chian Yong, Shek, Lynette P., Luong, Chan Quang, Fargo, Carina, Wartel, T. Anh, Sun, Sunny, Skipetrova, Anna, Bouckenooghe, Alain
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2019
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6816352/
https://ncbi.nlm.nih.gov/pubmed/30724660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1578595
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados